Are you Dr. Chakravarty?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 56 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
820 NE 15th St
Oklahoma City, OK 73104Phone+1 405-271-6242Fax+1 405-271-2887
Summary
- Dr. Eliza (Farmer) Chakravarty, MD is a rheumatologist in Oklahoma City, Oklahoma. She is currently licensed to practice medicine in Oklahoma and California. She is affiliated with Oklahoma Children’s Hospital OU Health and SSM Health St. Anthony Hospital - Oklahoma City.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Rheumatology, 2001 - 2003
Santa Clara Valley Medical CenterResidency, Internal Medicine, 1997 - 2001
Johns Hopkins University School of MedicineClass of 1997
Certifications & Licensure
CA State Medical License 1998 - 2024
OK State Medical License 2011 - 2024- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma) Start of enrollment: 2008 Nov 01
- Safety of Zostavax Vaccination in Rheumatoid Arthritis Start of enrollment: 2012 Jan 01
- Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE) Start of enrollment: 2013 Nov 20
Publications & Presentations
PubMed
- Hydroxychloroquine and Pre-eclampsia in a Diverse Cohort of Women With Systemic Lupus Erythematosus.Julia F Simard, Emily F Liu, Amadeia Rector, Miranda Cantu, Eliza Chakravarty
Arthritis Care & Research. 2024-10-01 - 1 citationsHydroxychloroquine in Lupus Pregnancy and Risk of Preeclampsia.Amadeia Rector, Ivana Marić, Yashaar Chaichian, Eliza Chakravarty, Miranda Cantu
Arthritis & Rheumatology. 2024-06-01 - Pregnancy Outcomes in a Diverse US Lupus Cohort.Julia F Simard, Emily F Liu, Eliza Chakravarty, Amadeia Rector, Miranda Cantu
Arthritis Care & Research. 2024-04-01
Press Mentions
OMRF Receives $3.8 Million to Study Autoimmune DiseasesAugust 12th, 2024- Challenges in Reproductive Health in Rheumatic DiseaseJuly 11th, 2022
- Should We Fear Covid Variants?July 3rd, 2021
- Join now to see all
Grant Support
- Efficacy Of Abatacept In Patients With Diffuse Systemic SclerosisNational Center For Research Resources2008
- Clinical Trial: Rituximab In Subjects With Moderate To Severe Systemic Lupus EryNational Center For Research Resources2008
- Clinical Trial: Rituximab In Subjects With Isn/Rps Class III Or IV Lupus NephritNational Center For Research Resources2008
- Treatment Of Active SLE And The Prevention Of Subsequent Lupus FlaresNational Center For Research Resources2007
- Rituximab In Subjects With Isn/Rps Class III Or IV Lupus NephritisNational Center For Research Resources2007
- Rituximab In Subjects With Moderate To Severe Systemic Lupus ErythematosusNational Center For Research Resources2006–2007
Professional Memberships
- Member
- Fellow
